Recombinant Human KPTN Protein: Handling & Usage Protocol

Recombinant Human KPTN Protein is a purified research-grade reagent designed for use in biochemical and cell-based assays investigating KPTN function in actin cytoskeleton organization and mTORC1 signaling pathway studies.

Product Name

Recombinant Human KPTN Protein

SKU

rp375157

Protein Origin

Human (Homo sapiens)

Protein Type

Recombinant protein

Primary Application

Biochemical assays, protein interaction studies, mTORC1 pathway research

Recommended Storage

Store at -80°C; avoid repeated freeze-thaw cycles

Background: KPTN Protein Biology

KPTN (Kaptin) is an actin-associated protein encoded by the KPTN gene in humans. It is widely expressed in neuronal and non-neuronal tissues and plays a critical role in regulating actin filament dynamics, particularly at the barbed ends of actin filaments within cellular structures such as stereocilia and growth cones.

Recent research has identified KPTN as a component of the KICSTOR complex, which acts as a negative regulator of mTORC1 (mechanistic target of rapamycin complex 1) signaling. Through its participation in the KICSTOR complex, KPTN contributes to amino acid sensing upstream of mTORC1, making it relevant to studies of cell growth, metabolism, and nutrient sensing.

Mutations in the KPTN gene have been associated with intellectual disability and macrocephaly in human patients, underscoring its physiological importance in central nervous system development. Recombinant Human KPTN Protein (rp375157) enables in vitro investigation of these diverse molecular functions.

Materials and Equipment Required

• Recombinant Human KPTN Protein, SKU rp375157 (Aladdin Scientific)
• Sterile, ultrapure water (18.2 MΩ·cm) or reconstitution buffer as specified on the Certificate of Analysis (CoA)
• Phosphate-buffered saline (PBS), pH 7.4, sterile-filtered
• Carrier protein (e.g., 0.1–0.5% BSA, protease-free) if required for dilution stability
• Low-binding microcentrifuge tubes (1.5 mL)
• Calibrated micropipettes and sterile tips
• Benchtop microcentrifuge
• Ice bucket or cooling block
• −80°C freezer for long-term storage
• SDS-PAGE and Western blot reagents (for quality verification, optional)

Step-by-Step Reconstitution and Handling Protocol

Step 1 — Preparation. Allow the lyophilized protein vial to equilibrate to room temperature for 10–15 minutes before opening. This minimizes condensation and prevents moisture contamination during reconstitution.

Step 2 — Reconstitution. Consult the Certificate of Analysis (CoA) supplied with SKU rp375157 for the manufacturer-recommended reconstitution volume and buffer. Gently add the specified volume of sterile water or reconstitution buffer along the wall of the vial. Do not vortex; instead, gently swirl or pipette slowly to dissolve the protein completely.

Step 3 — Centrifugation. Briefly centrifuge the reconstituted vial at 500–1000 × g for 30 seconds to collect any residual material from the vial walls and cap.

Step 4 — Aliquoting. Divide the reconstituted protein into single-use aliquots using low-binding microcentrifuge tubes to minimize protein loss through adsorption and to avoid repeated freeze-thaw cycles, which can degrade protein integrity.

Step 5 — Storage. Snap-freeze aliquots in liquid nitrogen or on dry ice, then transfer to −80°C storage. For short-term use (≤1 week), aliquots may be held at 4°C. Refer to the CoA for the specific stability data applicable to rp375157.

Step 6 — Working Dilution. Thaw one aliquot on ice immediately before use. Dilute to the desired working concentration in assay-compatible buffer (e.g., PBS pH 7.4 ± 0.1% BSA). Determine optimal concentration empirically for each assay type.

Quality Verification and Troubleshooting

Purity Assessment. Verify protein purity by running an SDS-PAGE gel alongside a molecular weight marker. Refer to the CoA for the expected molecular weight of the KPTN protein. A single major band at the expected position indicates acceptable purity. If multiple bands are observed, review reconstitution conditions and ensure reagents are free from contamination.

Activity Confirmation. Where applicable, confirm protein activity using a validated binding assay or co-immunoprecipitation experiment with known KPTN interaction partners (e.g., members of the KICSTOR complex). Consult the literature for appropriate positive and negative controls.

Troubleshooting Common Issues:

• Protein aggregation: Centrifuge at 10,000 × g for 5 minutes at 4°C to pellet aggregates before use. Consider adding a mild detergent (0.01% Tween-20) or reducing the protein concentration.
• Low yield after reconstitution: Ensure complete wetting of lyophilized cake; extend gentle mixing time. Confirm pipette calibration.
• Loss of activity: Check freeze-thaw history. Never use a vial that has been freeze-thawed more than the number of times specified on the CoA.

Downstream Applications and Experimental Considerations

Recombinant Human KPTN Protein (rp375157) is suitable for a range of research applications, including but not limited to:

• Protein–protein interaction studies: KPTN interacts with KICSTOR complex components; pull-down and co-IP experiments can be used to map binding interfaces.
• mTORC1 signaling assays: KPTN-containing KICSTOR complex suppresses mTORC1 activity under amino acid-deficient conditions; use in cell-free reconstitution or cell-based rescue experiments.
• Actin dynamics assays: Investigate KPTN's role in actin filament capping using pyrene-actin polymerization assays.
• Structural studies: Suitable as an antigen for antibody production or as a component in structural biology experiments (e.g., cryo-EM, X-ray crystallography) subject to sufficient quantity and purity.

Important Considerations: Always include appropriate controls (vehicle control, denatured protein negative control). Optimize protein concentration for each specific assay. Consult the product CoA and relevant literature before designing experiments to ensure the protein format (e.g., tag presence, expression system) is compatible with the intended application.

Frequently asked questions

How should Recombinant Human KPTN Protein (rp375157) be stored to maintain stability?

For long-term storage, keep lyophilized or reconstituted aliquots at −80°C and avoid repeated freeze-thaw cycles. Once reconstituted, divide into single-use aliquots immediately. Short-term storage at 4°C is acceptable for up to one week; always consult the Certificate of Analysis for product-specific stability data.

What reconstitution buffer is recommended for Recombinant Human KPTN Protein?

The recommended reconstitution buffer and volume are specified on the Certificate of Analysis (CoA) provided with each vial of rp375157. In the absence of specific instructions, sterile ultrapure water or PBS (pH 7.4) supplemented with a carrier protein such as 0.1% BSA is commonly used. Always follow the CoA guidance to ensure optimal solubility and activity.

What are the main research applications for Recombinant Human KPTN Protein?

Recombinant Human KPTN Protein is used in protein–protein interaction studies (particularly involving the KICSTOR complex and mTORC1 pathway), actin filament dynamics assays, cell-free reconstitution experiments, and as an antigen for antibody generation. It is valuable for researchers studying cell growth regulation, amino acid sensing, and neurological disorders associated with KPTN mutations.

How can I verify the quality of the reconstituted KPTN protein before use in experiments?

Quality can be assessed by SDS-PAGE to confirm the expected molecular weight and purity (a single predominant band is expected). For functional verification, a validated binding assay with a known KPTN interaction partner or a co-immunoprecipitation experiment can confirm activity. Always compare results with the purity and specification data on the CoA.

Why is it important to avoid repeated freeze-thaw cycles with recombinant proteins like KPTN?

Repeated freeze-thaw cycles promote protein aggregation, denaturation, and loss of biological activity due to ice crystal formation and concentration-dependent stress during each cycle. Single-use aliquots prepared at reconstitution prevent these issues and ensure each experiment uses protein of consistent quality.

References

1. Baple EL, et al. Mutations in KPTN cause macrocephaly, neurodevelopmental delay, and epilepsy. Am J Hum Genet. 2014.
2. Peng M, et al. KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1. Nature. 2017.
3. Bearer EL, et al. Actin dynamics in dendritic spines: actin filament assembly at the barbed end is linked to synaptic plasticity.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.